Skip to main content
. 2021 Jul 3;12(17):5296–5309. doi: 10.7150/jca.56138

Figure 6.

Figure 6

Enhanced survival of oral cancer patients with lower levels of miR-133 and PDE1C. (A) The relative expression levels of three different miR-133s (miR-133a-1 (miR-133a-5p), miR-133a-2 (miR-133a-3p) and miR-133b) and PDE1C are compared between 236 control and 145 OSCC tumor samples deduced from Broad GDAC Firehose (https://gdac.broadinstitute.org/) (see Materials and Methods for details). (B) The survival rates of OSCC patients with differential expression of miR-133s and PDE1C are visualized for comparisons. The significance level of a single analysis is indicated in each plot.